WallStreetZenWallStreetZen

NASDAQ: CERT
Certara Inc Stock

$17.44-0.23 (-1.3%)
Updated Apr 15, 2024
CERT Price
$17.44
Fair Value Price
$7.73
Market Cap
$2.79B
52 Week Low
$11.81
52 Week High
$24.96
P/E
-49.83x
P/B
2.66x
P/S
7.89x
PEG
N/A
Dividend Yield
N/A
Revenue
$354.34M
Earnings
-$55.36M
Gross Margin
60.2%
Operating Margin
-9.1%
Profit Margin
-15.6%
Debt to Equity
0.49
Operating Cash Flow
$83M
Beta
1.4
Next Earnings
May 6, 2024
Ex-Dividend
N/A
Next Dividend
N/A

CERT Overview

Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, Australia, and China. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CERT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CERT ($17.44) is overvalued by 125.6% relative to our estimate of its Fair Value price of $7.73 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CERT ($17.44) is not significantly undervalued (125.6%) relative to our estimate of its Fair Value price of $7.73 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CERT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CERT due diligence checks available for Premium users.

Be the first to know about important CERT news, forecast changes, insider trades & much more!

CERT News

Valuation

CERT fair value

Fair Value of CERT stock based on Discounted Cash Flow (DCF)
Price
$17.44
Fair Value
$7.73
Overvalued by
125.60%
CERT ($17.44) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CERT ($17.44) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CERT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CERT price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-49.83x
Industry
76.4x
Market
41.94x

CERT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.66x
Industry
3.43x
CERT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CERT's financial health

Profit margin

Revenue
$88.0M
Net Income
-$12.5M
Profit Margin
-14.2%
CERT's Earnings (EBIT) of -$32.23M... subscribe to Premium to read more.
Interest Coverage Financials
CERT's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$1.6B
Liabilities
$516.3M
Debt to equity
0.49
CERT's short-term assets ($340.20M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CERT's long-term liabilities ($386.28M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CERT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CERT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$23.3M
Investing
-$61.0M
Financing
-$1.3M
CERT's operating cash flow ($82.76M)... subscribe to Premium to read more.
Debt Coverage Financials

CERT vs Health Information Service Stocks

TickerMarket Cap1d %P/EP/B
CERT$2.79B-1.30%-49.83x2.66x
GDRX$2.59B-4.10%-327.50x3.40x
PINC$2.49B-1.61%14.82x1.04x
PGNY$3.26B-1.14%52.02x5.90x
TDOC$2.26B-4.64%-10.11x0.97x

Certara Stock FAQ

What is Certara's quote symbol?

(NASDAQ: CERT) Certara trades on the NASDAQ under the ticker symbol CERT. Certara stock quotes can also be displayed as NASDAQ: CERT.

If you're new to stock investing, here's how to buy Certara stock.

What is the 52 week high and low for Certara (NASDAQ: CERT)?

(NASDAQ: CERT) Certara's 52-week high was $24.96, and its 52-week low was $11.81. It is currently -30.13% from its 52-week high and 47.67% from its 52-week low.

How much is Certara stock worth today?

(NASDAQ: CERT) Certara currently has 159,855,345 outstanding shares. With Certara stock trading at $17.44 per share, the total value of Certara stock (market capitalization) is $2.79B.

Certara stock was originally listed at a price of $33.59 in Dec 14, 2020. If you had invested in Certara stock at $33.59, your return over the last 3 years would have been -48.08%, for an annualized return of -19.63% (not including any dividends or dividend reinvestments).

How much is Certara's stock price per share?

(NASDAQ: CERT) Certara stock price per share is $17.44 today (as of Apr 15, 2024).

What is Certara's Market Cap?

(NASDAQ: CERT) Certara's market cap is $2.79B, as of Apr 16, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Certara's market cap is calculated by multiplying CERT's current stock price of $17.44 by CERT's total outstanding shares of 159,855,345.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.